Clinical Trial Update: China Antihypertensive Trial for Intracranial Aneurysm (ChATIA-1) [NA]

View source ↗

Summary

The China Antihypertensive Trial for Intracranial Aneurysm (ChATIA-1) has completed, investigating an antihypertensive approach for unruptured intracranial aneu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unruptured Intracranial Aneurysm

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Unruptured Intracranial Aneurysm | NA | Status: COMPLETED